Mablink presents at the digital 9th Antibody Industrial Symposium (June 22-25, 2021)
Our Chief Scientific Officer, Dr Warren Viricel, is giving a presentation at the 9th virtual Antibody Industrial Symposium (AIS) on Wednesday, June 22.
Dr Viricel gives a talk in the “track” “New trends in ADCs Development” describing the current industry move, in which Mablink participates with its own ADC programs, “Towards more hydrophilic and better tolerated Antibody-Drug Conjugates (ADC)”.
About the Antibody Industrial Symposium:
The Antibody Industrial Symposium is part of the series of Industrial Symposia organized by MAbImprove since 2013, whose previous topics were: Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates, Targets for Mabs, Harnessing the Immune System with Abs, and Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases.
The AIS2021 is the ideal conference for scientists, industrials, physicians and policy makers to exchange about therapeutic antibodies and more.
Visit the AIS website here for more information.